Formulation and Evaluation of Β-Cyclodextrin Inclusion Complexes of Dolutegravir Sodium for Solubility Enhancement
Santosh Kokitakar, Twarita D. Deshpande, Onkar V. Jadhav & UB Bolmal · Advances in Research · 2025
Background: Dolutegravir sodium, a second-generation integrase strand transfer inhibitor used in the treatment of HIV, exhibits high permeability but poor aqueous solubility, thereby classifying it as a BCS Class II compound. Poor solubility limits its oral bioavailability, neces...
Open access
Research Article
10.9734/air/2025/v26i61525